Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...
SOUTH JORDAN, Utah, March 10, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, ...
The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the first medical device to treat patent ductus arteriosus (PDA) in premature babies weighing as little ...
In a rare and inspiring medical achievement, a hospital in Navi Mumbai has successfully saved a micro-preemie born at just 23 ...
An extremely premature infant, medically classified as a micro-preemie, a term used for babies born before 26 weeks of ...
Motherhood Hospitals, Kharghar in Navi Mumbai successfully saved a micro-preemie born at just 23 weeks and 6 days of pregnancy, weighing only 690 grams ...
Merit Medical Systems, Inc. MMSI, on Monday, announced the enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback